4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-23-004945
Chief Medical Officer sold 30,000 shares at $30.00 ($900,057)
- Chief Medical Officer acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2023-01-24 | Grant or award | +25,406 | $1.58 | $40,014 | 169,406 | D |
| Pang Phillip Chief Medical Officer | 2023-01-24 | Grant or award | +4,594 | $5.18 | $23,774 | 174,000 | D |
| Pang Phillip Chief Medical Officer | 2023-01-24 | Sale | −30,000 | $30.00 | $900,057 | 144,000 | D |
| Derivatives | |||||||
| Pang Phillip Chief Medical Officer | 2023-01-24 | Option exercise · Stock Option (Right to Buy) | −25,406 | 13,576 | D | ||
| Pang Phillip Chief Medical Officer | 2023-01-24 | Option exercise · Stock Option (Right to Buy) | −4,594 | 37,535 | D | ||
| Open-market sales · 30,000 sh · avg $30.00 · $900,057 | |||||||
Loading xslF345X03/doc4.xml…